MetLife (NYSE: MET) director receives 721 deferred stock shares

Rhea-AI Filing Summary

Harris Carla A reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Carla A. Harris received an award of 721 shares of common stock as part of non-management director compensation. The shares were valued at $71.17 each and are being deferred under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this grant, Harris directly holds 10,485 shares of MetLife common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Harris Carla A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$71.17	$51K

Holdings After Transaction: Common Stock — 10,485 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 721 shares Grant value per share: $71.17 per share Shares held after grant: 10,485 shares +1 more

4 metrics

Shares granted 721 shares Award of common stock to director Carla A. Harris

Grant value per share $71.17 per share Recorded value of common stock award

Shares held after grant 10,485 shares Total direct MetLife holdings after transaction

Transaction date 2026-04-01 Effective date of compensation-related stock grant

Key Terms

Common Stock, non-management director retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-management director retainer fees financial

"non-management director compensation arrangements pay a portion of non-management director retainer fees"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harris Carla A

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$71.17	10,485	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) report for Carla A. Harris?

MetLife reported that director Carla A. Harris received an award of 721 shares of common stock. This was part of her non-management director compensation, increasing her direct holdings to 10,485 shares after the transaction.

Was the Carla A. Harris MetLife (MET) transaction a market purchase or sale?

The transaction was not a market trade. Carla A. Harris received 721 MetLife shares as a grant or award tied to non-management director compensation, rather than buying or selling shares on the open market.

At what price were Carla A. Harris’s MetLife (MET) shares recorded in the grant?

The 721 MetLife common shares granted to Carla A. Harris were recorded at $71.17 per share. This reflects the value used for the compensation award, not an open-market purchase price.

How many MetLife (MET) shares does Carla A. Harris hold after this Form 4 transaction?

After the award of 721 shares, Carla A. Harris holds 10,485 MetLife common shares directly. This total reflects her position immediately following the reported compensation-related share grant.

How were Carla A. Harris’s MetLife (MET) director fees paid according to the filing?

A portion of Carla A. Harris’s non-management director retainer fees was paid in MetLife common stock. She elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.